Unknown

Dataset Information

0

A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm.


ABSTRACT: Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive and largely incurable hematologic malignancy originating from plasmacytoid dendritic cells (pDCs). Using RNAi screening, we identified the E-box transcription factor TCF4 as a master regulator of the BPDCN oncogenic program. TCF4 served as a faithful diagnostic marker of BPDCN, and its downregulation caused the loss of the BPDCN-specific gene expression program and apoptosis. High-throughput drug screening revealed that bromodomain and extra-terminal domain inhibitors (BETis) induced BPDCN apoptosis, which was attributable to disruption of a BPDCN-specific transcriptional network controlled by TCF4-dependent super-enhancers. BETis retarded the growth of BPDCN xenografts, supporting their clinical evaluation in this recalcitrant malignancy.

SUBMITTER: Ceribelli M 

PROVIDER: S-EPMC5175469 | biostudies-literature | 2016 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications


Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive and largely incurable hematologic malignancy originating from plasmacytoid dendritic cells (pDCs). Using RNAi screening, we identified the E-box transcription factor TCF4 as a master regulator of the BPDCN oncogenic program. TCF4 served as a faithful diagnostic marker of BPDCN, and its downregulation caused the loss of the BPDCN-specific gene expression program and apoptosis. High-throughput drug screening revealed that bromod  ...[more]

Similar Datasets

2016-11-15 | GSE75650 | GEO
2016-11-15 | GSE76147 | GEO
2016-11-15 | GSE84623 | GEO
2016-11-15 | GSE84471 | GEO
| S-EPMC10932245 | biostudies-literature
| S-EPMC4735436 | biostudies-literature
| S-EPMC6467341 | biostudies-literature
| S-EPMC7094006 | biostudies-literature
| S-EPMC7448601 | biostudies-literature